Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interim Buprenorphine vs. Waiting List for Opioid Dependence.

Literature DB >> 28002704

Interim Buprenorphine vs. Waiting List for Opioid Dependence.

Stacey C Sigmon¹, Taylor A Ochalek¹, Andrew C Meyer¹, Bryce Hruska¹, Sarah H Heil¹, Gary J Badger¹, Gail Rose¹, John R Brooklyn¹, Robert P Schwartz², Brent A Moore³, Stephen T Higgins⁴.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2016 PMID： 28002704 PMCID： PMC5373028 DOI： 10.1056/NEJMc1610047

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

5 in total

1. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type.

Authors: Leonard J Paulozzi; Yongli Xi
Journal: Pharmacoepidemiol Drug Saf Date: 2008-10 Impact factor: 2.890

2. Pharmaceutical overdose deaths, United States, 2010.

Authors: Christopher M Jones; Karin A Mack; Leonard J Paulozzi
Journal: JAMA Date: 2013-02-20 Impact factor: 56.272

3. New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors: A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal: J Nerv Ment Dis Date: 1985-07 Impact factor: 2.254

4. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors: Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal: Addict Behav Date: 2015-07-29 Impact factor: 3.913

5. Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry.

Authors: Einat Peles; Shaul Schreiber; Miriam Adelson
Journal: J Addict Med Date: 2013 May-Jun Impact factor: 3.702

5 in total

26 in total

1. Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors: Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal: J Subst Abuse Treat Date: 2019-05-09

2. A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.

Authors: Michael S Gordon; Frank J Vocci; Faye Taxman; Marc Fishman; Bikash Sharma; Thomas R Blue; Kevin E O'Grady
Journal: Contemp Clin Trials Date: 2019-02-20 Impact factor: 2.226

3. Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study.

Authors: Tamara Beetham; Brendan Saloner; Sarah E Wakeman; Marema Gaye; Michael L Barnett
Journal: Ann Intern Med Date: 2019-06-04 Impact factor: 25.391

4. Innovations in efforts to expand treatment for opioid use disorder.

Authors: Stacey C Sigmon
Journal: Prev Med Date: 2019-08-21 Impact factor: 4.018

5. Commentary on "The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible".

Authors: Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz
Journal: J Addict Med Date: 2018 Nov/Dec Impact factor: 3.702

Review 6. Combining ecological momentary assessment with objective, ambulatory measures of behavior and physiology in substance-use research.

Authors: Jeremiah W Bertz; David H Epstein; Kenzie L Preston
Journal: Addict Behav Date: 2017-11-16 Impact factor: 3.913

Review 7. Opioid use disorder.

Authors: John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal: Nat Rev Dis Primers Date: 2020-01-09 Impact factor: 52.329